Earnings Call · Q3 FY2023·2023-11-07

Q3 23EPS +100.00%*·Rev n/aQ2 23EPS +17.20%·Rev n/aQ1 23EPS +20.39%·Rev n/aQ4 22EPS +3.74%·Rev n/a⚠ consensus missing

Travere Therapeutics, Inc. TVTX

Naomi Eichenbaum — Vice President of Investor Relations

Dr. Eric Dube — Chief Executive Officer

Dr. Jula Inrig — Chief Medical Officer

Peter Heerma — Chief Commercial Officer

Chris Cline — Chief Financial Officer

−11.8%1d on move date−11.9% vs SPY3d−22.3%5d−15.2%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TVTX calls or request research access.

More TVTX calls Browse calls Request research access